chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient told mom that everything was "kind of gray" after he received vaccines at school. School took temp and it was ok. He finished school day without any other problems. Vision was ok when he arrived home from school. He woke up at 12:45 with a fever greater than 104 degrees he states that his stomach hurt, nauseated before bedtime but did not throw up. Mom gave TYLENO/MOTRIN and a tepid bath/. Temp down to 100 degrees in about 1 and 1/2 hours. No fever complaints after this.
This initial spontaneous report as received from a nurse concerning a child of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug allergies/drug reactions and concomitant medications were unknown per reporter. On 28-OCT-2021, another child of 6-years old was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, frequency, route, Lot # and expiration date not reported) for prophylaxis. It was reported that the patient had the same babysitter as one of the other children and developed spots. The nurse stated that the 6-year-old child was suspected to have spread the illness to the patient. It was stated that after speaking with the nurses that day it was verify that the child did not seek medical attention and there was never a confirmed case of chicken pox. The nurse's supervisor stated that she did not think it was chicken pox and instead Hand-foot-mouth disease. The nurse also reported that they had spoken to the state immunization advisor about this situation and that the advisor was not considering this to be a confirmed case of varicella as there was not Polymerase Chain Reaction (PCR) testing performed. At the time of the report, the outcome of rash macular, secondary transmission and hand-foot-and-mouth disease was unknown. The causal relationship between the events and vaccination with varicella virus vaccine live (oka/merck) (VARIVAX) was unknown. This is one of several cases from the same source.; Sender's Comments: US-009507513-  2112USA005507: US-009507513-2111USA006313.
On Saturday I awoke with a fever and severely swollen arm and lymph nodes. I was icing the arm and was very worried. By Sunday my arm was going numb and I was waiting for the symptons to subside. I continued with acetaminophen and icing the arm. By Monday morning I called my doctor and was rushed in to see him.
Palpitations worse than chemical stress test; Headache; Vomiting; This spontaneous case was reported by a patient and describes the occurrence of PALPITATIONS (Palpitations worse than chemical stress test), HEADACHE (Headache) and VOMITING (Vomiting) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PALPITATIONS (Palpitations worse than chemical stress test), HEADACHE (Headache) and VOMITING (Vomiting). At the time of the report, PALPITATIONS (Palpitations worse than chemical stress test), HEADACHE (Headache) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The  concomitant medications on use were not provided.  No laboratory data was provided.   No treatment information was provided.
The patient is experiencing chills and nausea. She came in at approximately 3:45pm ET on 9/30/18 and reported she had been experiencing the symptoms for about 3 hours and never had any side effects with past flu vaccines.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Shakiness-Medium, Additional Details: Patient reported feeling in a dream like state and woke up to me holding him.  Pharmacist on duty was holding him to keep him steady/not fall over.  Had pulse and respiration was normal, BP was 127/92.  Technician called 911 while pharmacist was observing patient.   EMS arrived to take patient for observation outside of facility.
exposed to Poison Ivy 5 days after her Moderna Covid-19 booster dose; developed a skin rash; tired; right arm injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO TOXIC AGENT (exposed to Poison Ivy 5 days after her Moderna Covid-19 booster dose), VACCINATION SITE PAIN (right arm injection site soreness), FATIGUE (tired) and RASH (developed a skin rash) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 012M20A and 025120-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 25-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (right arm injection site soreness). On 26-Oct-2021, the patient experienced FATIGUE (tired). On 30-Oct-2021, the patient experienced EXPOSURE TO TOXIC AGENT (exposed to Poison Ivy 5 days after her Moderna Covid-19 booster dose) and RASH (developed a skin rash). At the time of the report, EXPOSURE TO TOXIC AGENT (exposed to Poison Ivy 5 days after her Moderna Covid-19 booster dose), VACCINATION SITE PAIN (right arm injection site soreness) and FATIGUE (tired) outcome was unknown and RASH (developed a skin rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter.  Patient took injectable steroid and was placed on a steroid dose pack.   This case was linked to MOD-2022-526482, MOD-2022-526433 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2022: Follow up received contain non significant information.
Pain in arm, very tired and slight chills and achy at night. Mostly fine. Just wanted to report that I woke at 4:30am and was very nauseous and dizzy. I went to the bathroom and thought I would be sick, but I remember being so dizzy that I went to lay on the floor by the toilet but my husband said he heard a thud, and came to find me passed out. Then I was shaking  (a vaso vagel response I guess) til I came to. The ems came, but everything was fine, so I elected to stay home. I threw up a 1/2 hour later and then felt better, and slept for a few hours. The rest of the day I was just exhausted. Today I woke up feeling fine! Just wanted to report the episode in case you track vomiting and dizziness and fainting.
Large erythematous area around injection sight. Swelling. Occured the following day after vaccination (1/6), resolved, then flared up in same spot on 1/12. Additional symptoms include pain at the injection site, and lymphadenopathy and pain in the left axilla.
Pt was given Pfizer vaccine 2nd dose to the right deltoid at 1253pm. Pt called nurse over at 1315 stating that she felt slight tightness in her throat. Pt vitals are 90% room air pulse of 82. At 1320 patient was give 25mg of liquid benadryl per standing orders. Nurse rechecked at 1335 patient stated the tightness in her throat was much better and patient was then transported home by her husband.
This literature marketed report was received from the authors in a published literature article titled as stated above, regarding a child  male patient, which age was reported as 1.11 years; from an initial group of 204 patients (84 female and 120 male patients; enrolled in a study, which aim  was to evaluate the safety of live virus vaccines and the characteristics of the recipient population that are associated with successful live virus vaccination (LVV) post liver transplant (LT). The patient's concurrent conditions included biliary atresia. On an unknown date, the patient received a LT, along with an immunosuppressive regimen of sirolimus (dose, route and frequency were not reported). It was reported that,  pre-transplant, the patient was Negative for the IgG of the corresponding vaccine  On an unknown date, before the LT,  the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (lot #, expiration date, dose, route and frequency were not reported) for prophylaxis, along with varicella virus vaccine live (oka/merck)(manufacturer unknown) (lot #, expiration date, dose, route and frequency were not reported) for prophylaxis.    On an unknown date, the patient underwent a LT, due to her biliary atresia. On an unknown date, the patient experienced fever that was considered a side effect from the received vaccinations.  At the reporting time, the outcome of fever was not reported. The authors considered the event to be related to measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (lot #, expiration date, dose, route and frequency were not reported) for prophylaxis, along with varicella virus vaccine live (oka/merck)(manufacturer unknown).  A copy of the published article is attached as further documentation of the patient's experience.  This is one of several reports obtained from the same literature article.; Sender's Comments:  US-009507513-2201MEX008251: US-009507513-2202USA001021: US-009507513-2202USA001022:
Patient says she's had difficulty moving her arm since receiving her flu shot and it aches throughout the entire day.  She had not tried any interventions for pain yet. Recommended taking an NSAID for inflammation and swelling and hot pack.
Patient was vaccinated and waiting. Patient was still  waiting and went outside pharmacy where he had a syncope episode and fell. Patient was brought back inside the pharmacy where we laid him in a supine position with legs elevated. His blood pressure was checked. Patient was observed to have minor bruises on his left knee, hand, forehead, and minor cut on hand and under chin. After continued observation patient did not report any signs of dizziness or lightheadedness. Patient reported signs of pain from fall. Patient was given first aid - applying gauze and band aid. The cut on patient's chin was of concerned. Told patient to seek further medical care. Patient was released in the care of spouse.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 9:57 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 9:57 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The age of patient was provided as 22.51.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  On 27-Apr-2021, Excursion time was 09 AM temperature was 35, total doses given for the day was 42, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 19-Apr-2021, vial was moved to clinic on 27-Apr-2021. 08 vials were sent to clinic. Vaccine BUD date was 19-May-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. The temperature recordings were taken by using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.
10/23/2004: Pt received influenza vaccine, 10/24/2004- unsteady gait, left facial/ lip numbness, and numbness, and left ear pain. 10/29/2004- To ER with ataxia, Ophthalmoplegia, nausea and vomiting, hallucinations;declined neuro admit. DDX: Acute disseminating encephalomyelitis vs. paraneoplastic syndromes with CNS neoplasm. 11/01/2004-return to ER with worseninging of symptoms and admitted to neuro for presumed acute disseminenated encephalitis. Pt had multiple MRI's, treated with high dose of corticosteroids and IVIG ??, complicated by panytopenia and MRSA/pseudomonas bacteria. The pt expired on 12/13/2004. 6/7/05 Received hospital D/C summary which states admit DX: presumed ADEM (acute disseminated encephalomyelitis).  D/C DX: neuropathy of unknown origin, pancytopenia & MRSA/pseudamonas bacteremia.  PMH: HTN, CAD, s/p CABG 2003, prostate ca 2000.  MRI done 11/1 showed multiple lesions on the brainstem.  LP w/high WBC & protein.  By 11/4 MRI showed extension of the disease to involve most of the brainstem bilaterally.  Tx with high dose steroids & antibiotics.  Periods of intubation/extubation & developed aspiration pneumonia. MRI on 11/12 showed new lesions extending to the cerebellum with some improvement in the brainstem lesions.  Developed low platelet counts which prevented PEG & tracheostomy.  Tx w/IVIG, steroids & antibiotics. HIT antibody tes was + on 11/27 & started argatroban.  Stopped that when developed pancytopenia.  Became septic & blood c/s + for both MRSA & pseudamonas, acutely decompensated & expired.
chills; sweating; tired; high fever with reading 105F; severe chest pain; intense pressure starting in back and radiating in front...This pain was worst than fever; This is a spontaneous report from a contactable consumer(patient). A 38-years-old female patient received bnt162b2(Pfizer vaccine, formulation: solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29May2021 17:45 (Batch/Lot Number: EW0182) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included historical vaccine BNT162B2 as 1st dose single dose, administered in left arm on 08May2021 5:45pm (Lot no. EW0182) for covid 19 immunisation. Prior to the vaccination, the patient was not diagnosed with covid 19. Since the vaccination, had not been tested for covid 19. Allergies was not reported. Concomitant medications were not reported.The patient reported after 6 hours of her second dose, on 29May2021 02:00, she got a high fever with reading 105F along with severe chest pain. Chest pain started first, it seemed like intense pressure starting in back and radiating in front. This pain was worst than fever, she thought it was likely caused by gas, so took GasX  pill and did not help. This lasted for an hr, after that she got chills and then the fever. she tool Tylenol and then after sweating, fever was gone. After exact 4 Hrs, same thing started again with chest pain, chills, fever and sweating. This went on for 2 days. Even with Tylenol fever never came down below 100F and at the end of 4th hour it was always high in a range of 104F-105F. On 3rd day, she switched to ibuprufen and then fever didn't come after that. she felt very tired all 3rd day, but returned to normal activities on 4th day. The patient received Birth Control Pills within 2 weeks of vaccination as medications. Outcome of the events the patient experienced high fever with reading 105f, severe chest pain, intense pressure starting in back and radiating in front this pain was worst than fever recovered on unspecified date in 2021. Outcome of the other events was recovered on unspecified date.  Additional information has been requested.
Following the second vaccine - I was feeling fine - woke up next day with flu like sympthoms and dull headache / chills on and off all day - Only Lasted that day - had Shot on Tuesday - experienced these symptoms on Wednesday - Felt totally fine by Thursday and continue to feel perfectly fine.  - Did not feel ill enough to contact my doctor.
Grand Mal Seizure 3 days after injection. I was brought to the ER and had tests done.  I had a clear EEG, EKG, CAT scan, and MRI. I am now on Keppra.
DIZZINESS/SWEATING, BRIEF LOSS OF CONCIOUSNESS, COLD PRESSURE APPLIED, HYDRATION PROVIDED, SX RESOLVED, REFUSED TRANSPORT
Pt's mother states after coming to clinic and getting the shot pt had seizure like reaction. Pt's mother believes due to vaccine.
tired/lethargic; no sense of hunger; severe abdominal cramping; 2 episodes of diarrhea; no nausea straight vomiting; tired/lethargic; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (tired/lethargic), APPETITE DISORDER (no sense of hunger), ABDOMINAL PAIN (severe abdominal cramping), DIARRHOEA (2 episodes of diarrhea) and VOMITING (no nausea straight vomiting) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EN6204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history.  The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), CELECOXIB (CELEXA [CELECOXIB]), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), VITAMIN D [VITAMIN D NOS], CHORIONIC GONADOTROPHIN (PROVIGIL [CHORIONIC GONADOTROPHIN]) and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced LETHARGY (tired/lethargic), APPETITE DISORDER (no sense of hunger), ABDOMINAL PAIN (severe abdominal cramping), DIARRHOEA (2 episodes of diarrhea), VOMITING (no nausea straight vomiting) and FATIGUE (tired/lethargic). The patient was treated with FAMOTIDINE (PEPCID AC) ongoing since an unknown date for Diarrhea, at an unspecified dose and frequency. At the time of the report, LETHARGY (tired/lethargic), APPETITE DISORDER (no sense of hunger), ABDOMINAL PAIN (severe abdominal cramping), DIARRHOEA (2 episodes of diarrhea), VOMITING (no nausea straight vomiting) and FATIGUE (tired/lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included pepcid.
This spontaneous report was received from a medical assistant (healthcare worker) regarding an unspecified number of patients. The patients demographics were unkonwn. There was no pertinent medical history and drug reaction or allergies of the patients reported. On unspecified dates, an unspecified patients were vaccinated with an PNEUMOVAX 23 (dose, route, product lot and expiry date was not reported) that might had been improperly stored. No adverse effects reported. There was no product quality complaint involved. This is one of the several reports from the same reporter. Additional information has been requested.
DOSING ERROR (VACCINATION ADMINISTERED TOO CLOSE  TOGETHER Patient received first COVID vaccine 2/27/21. Herpes zoster recombinant vaccine was administered only a couple days later on 3/1/21. Order for Herpes zoster had been activated 12/17/20. Vaccine given 3/1 per active order and pursuant to clinical reminder. No noted adverse reaction related to this administration error.
Report a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report a side effect). At the time of the report, VACCINATION COMPLICATION (Report a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products and treatment medication were provided.   Reporter did not allow further contact
Patient states arm became red approximately 3 inches below injection site. Went to Urgent Care on 9/13/2018 and was diagnosed with cellulitis.
17 years old female patient called on 02Apr2021 to report that she received the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old female patient called on 02Apr2021 to report that she received the first dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old female patient called on 02Apr2021 to report that she received the first dose). On 16-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old female patient called on 02Apr2021 to report that she received the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment details were provided.  This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: Not Provided) with no associated AEs.; Sender's Comments: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: Not Provided) with no associated AEs.
Experienced low-grade fever of100 degrees F, chills and muscle aches about roughly 12 hours after receiving vaccine on 3-31-2021. Took Tylenol to help with symptoms. Symptoms were mild overall and I was  mostly recovered by the evening of 4-1-2021.
pt devel welt lt deltoid @ inj site 5min p/vax;pt given PDH;
Client reported mild itching in left arm approximately 10 minutes after receiving vaccine. No shortness of breath noted, alert and oriented with no known drug allergies and no history of anaphylaxis. Vital signs taken at 0705 reported as: BP 138/83, P 65 bpm, O2 99% on room air, temp 98.0 degrees Fahrenheit, all within normal limits reported from client. Stayed for 15 minutes longer and reported subsiding of itching in arm. Client discharged from area.